A Network Analysis of Multiple Myeloma Related Gene Signatures
Multiple myeloma (MM) is the second most prevalent hematological cancer. MM is a complex and heterogeneous disease, and thus, it is essential to leverage omics data from large MM cohorts to understand the molecular mechanisms underlying MM tumorigenesis, progression, and drug responses, which may ai...
Main Authors: | Yu Liu, Haocheng Yu, Seungyeul Yoo, Eunjee Lee, Alessandro Laganà, Samir Parekh, Eric E. Schadt, Li Wang, Jun Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/10/1452 |
Similar Items
-
Identification and validation of a novel cuproptosis-related gene signature in multiple myeloma
by: Bingxin Zhang, et al.
Published: (2023-04-01) -
A novel glycolysis-related gene signature for predicting the prognosis of multiple myeloma
by: Bingxin Zhang, et al.
Published: (2023-06-01) -
Development and Validation of a 9-Gene Prognostic Signature in Patients With Multiple Myeloma
by: Xiao-Ping Liu, et al.
Published: (2019-01-01) -
Early Normalization of Free Light Chains Predicts Better Outcomes in Patients with Multiple Myeloma
by: Rony Benson, et al.
Published: (2020-10-01) -
A gene signature can predict risk of MGUS progressing to multiple myeloma
by: Fumou Sun, et al.
Published: (2023-06-01)